М. I. Shkolnik
- Immunology top 10%
- Oncology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Cancer Research
- Co-authors
- B. Yа. AlekseevSimon J. CrabbKenneth J. PientaJean-Pascal MachielsThomas A. PuchalskiDirk SchrijversJohann S. de BonoChris H. Takimoto
- Topics
- Renal cell carcinoma treatment (7 papers)Prostate Cancer Treatment and Research (6 papers)Bladder and Urothelial Cancer Treatments (4 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaAnnals of Oncology
- Partner nations
- RussiaUnited StatesTaiwan
In The Last Decade
М. I. Shkolnik
15 papers receiving 448 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Immunology 267
- Oncology 235
- Molecular Biology 148
- Pulmonary and Respiratory Medicine 111
- Cancer Research 69
Countries citing papers authored by М. I. Shkolnik
This map shows the geographic impact of М. I. Shkolnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by М. I. Shkolnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites М. I. Shkolnik more than expected).
Fields of papers citing papers by М. I. Shkolnik
This network shows the impact of papers produced by М. I. Shkolnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by М. I. Shkolnik. The network helps show where М. I. Shkolnik may publish in the future.
Co-authorship network of co-authors of М. I. Shkolnik
This figure shows the co-authorship network connecting the top 25 collaborators of М. I. Shkolnik. A scholar is included among the top collaborators of М. I. Shkolnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with М. I. Shkolnik. М. I. Shkolnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 0 | |
| 13 | 0 | |
| 14 | 0 | |
| 15 | 0 | |
| 16 | 60 | |
| 17 | 1 | |
| 18 | 7 | |
| 19 | Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancerbreakdown → | 336 |
| 20 | Методы термодеструкции в лечении почечно-клеточного рака | 0 |
About М. I. Shkolnik
М. I. Shkolnik is a scholar working on Pulmonary and Respiratory Medicine, Urology and Oncology, having authored 27 papers that have together received 455 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (7 papers), Prostate Cancer Treatment and Research (6 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Immunology (267 citations), Oncology (235 citations) and Cancer Research (69 citations). М. I. Shkolnik has collaborated with scholars based in Russia, United States and Taiwan. Frequent co-authors include B. Yа. Alekseev, Simon J. Crabb, Kenneth J. Pienta, Jean-Pascal Machiels, Thomas A. Puchalski, Dirk Schrijvers, Johann S. de Bono, Chris H. Takimoto, Susan Li and Shobha Seetharam. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.